As part of our commitment to defeat degeneration, Denali encourages active engagement with the broader scientific community.
Selected publications that reflect our distinct scientific approach are highlighted below.
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Nature Neuroscience | January 12, 2023
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease
Science Translational Medicine | June 8, 2022
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice
Science Translational Medicine | May 27, 2020